Down’s syndrome and myocardial reperfusion injury

Arbuzova, 2002, Mitochondrial dysfunction and Down’s syndrome, Bioessays, 24, 681, 10.1002/bies.10138 Brugge, 1992, The role of alterations in free radical metabolism in mediating cognitive impairments in Down’s syndrome, EXS, 62, 190 Busciglio, 2002, Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down’s syndrome, Neuron, 33, 677, 10.1016/S0896-6273(02)00604-9 Conti, 2007, Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy, BMC Genomics, 8, 268, 10.1186/1471-2164-8-268 Pallardó, 2006, Multiple evidence for an early age pro-oxidant state in Down syndrome patients, Biogerontology, 7, 211, 10.1007/s10522-006-9002-5 Prince, 1994, Mitochondrial enzyme deficiencies in Down’s syndrome, J. Neural Transm. Park Dis. Dement. Sect., 8, 171, 10.1007/BF02260938 Shukkur, 2006, Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome, Hum. Mol. Genet., 15, 2752, 10.1093/hmg/ddl211 Sinha, 2005, Anti-oxidant gene expression imbalance, aging and Down syndrome, Life Sci., 76, 1407, 10.1016/j.lfs.2004.10.026 Tiano, 2008, Coenzyme Q10 and oxidative imbalance in Down syndrome: biochemical and clinical aspects, Biofactors, 32, 161, 10.1002/biof.5520320119 Wiseman, 2009, Down syndrome – recent progress and future prospects, Hum. Mol. Genet., 18, R75, 10.1093/hmg/ddp010 Yellon, 2007, Myocardial reperfusion injury, N. Engl. J. Med., 357, 1121, 10.1056/NEJMra071667 Zaldivar-Chiapa, 2005, Evaluation of surgical and non-surgical periodontal therapies and immunological status of young Down’s syndrome patients, J. Periodontol., 76, 1061, 10.1902/jop.2005.76.7.1061 Zigman, 2007, Alzheimer’s disease in Down syndrome: neurobiology and risk, Ment. Retard Dev. Disabil. Res. Rev., 13, 237, 10.1002/mrdd.20163